Corcept Therapeutics (CORT) Other Working Capital Changes (2010 - 2026)

Corcept Therapeutics (CORT) has 7 years of Other Working Capital Changes data on file, last reported at -$251000.0 in Q4 2025.

• For the quarter ending Q4 2025, Other Working Capital Changes fell 273.1% year-over-year to -$251000.0; the trailing twelve-month figure through Dec 2025 stood at -$829000.0 (down 553.01% YoY), and the FY2025 full-year result was -$829000.0, down 553.01% from the prior year.
• Other Working Capital Changes retreated to -$251000.0 in Q4 2025, from -$247000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $13.5 million in Q1 2025 to a low of -$11.3 million in Q2 2025.
• A 5-year average of $1.6 million and a median of $729000.0 in 2023 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes soared 297.22% in 2024 and sank 693.1% in 2025, its largest moves.
• Tracing CORT's Other Working Capital Changes over 5 years: stood at -$520000.0 in 2021, then retreated by 8.46% to -$564000.0 in 2022, then surged by 86.88% to -$74000.0 in 2023, then surged by 295.95% to $145000.0 in 2024, then slumped by 273.1% to -$251000.0 in 2025.
• Business Quant data shows CORT's Other Working Capital Changes at -$251000.0 in Q4 2025, -$247000.0 in Q3 2025, and -$230000.0 in Q2 2025.